Page last updated: 2024-10-14
chromopyrrolic acid
Description
chromopyrrolic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
chromopyrrolic acid : A pyrroledicarboxylic acid that is pyrrole-2,5-dicarboxylic acid in which the hydrogens at positions 3 and 4 have been replaced by indol-3-yl groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 11326613 |
CHEMBL ID | 491841 |
CHEBI ID | 41625 |
SCHEMBL ID | 12955978 |
MeSH ID | M0537006 |
Synonyms (16)
Synonym |
chromopyrrolic acid |
3,4-di-1h-indol-3-yl-1h-pyrrole-2,5-dicarboxylic acid |
DB07588 |
lycogalic acid a |
CHEMBL491841 |
bdbm50378456 |
lycogaric acid a |
150044-68-1 |
1h-pyrrole-2,5-dicarboxylic acid, 3,4-di-1h-indol-3-yl- |
SCHEMBL12955978 |
DTXSID90462496 |
C21125 |
CHEBI:41625 |
3,4-di(1h-indol-3-yl)-1h-pyrrole-2,5-dicarboxylic acid |
3,4-di(indol-3-yl)pyrrole-2,5-dicarboxylic acid |
Q27096807 |
Roles (1)
Role | Description |
bacterial metabolite | Any prokaryotic metabolite produced during a metabolic reaction in bacteria. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (2)
Class | Description |
indoles | Any compound containing an indole skeleton. |
pyrroledicarboxylic acid | A pyrrole compound having two carboxy substituents at any position on the ring. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein Targets (1)
Inhibition Measurements
Ceullar Components (1)
Bioassays (4)
Assay ID | Title | Year | Journal | Article |
AID447683 | Inhibition of mouse Hes1-mediated suppression of basic helix-loop-helix activator genes in C3H10T1/2 cells at 50 uM by luciferase transactivation assay | 2009 | Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
| The first Hes1 dimer inhibitors from natural products. |
AID447680 | Inhibition of Cy3-labeled mouse recombinant Hes1 (3-281) dimer formation expressed in Escherichia coli by microplate-based assay | 2009 | Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
| The first Hes1 dimer inhibitors from natural products. |
AID391903 | Antiviral activity against HSV | 2008 | Journal of natural products, Oct, Volume: 71, Issue:10
| Lynamicins A-E, chlorinated bisindole pyrrole antibiotics from a novel marine actinomycete. |
AID447682 | Inhibition of mouse Hes1-mediated suppression of basic helix-loop-helix activator genes in C3H10T1/2 cells by luciferase transactivation assay | 2009 | Bioorganic & medicinal chemistry letters, Oct-01, Volume: 19, Issue:19
| The first Hes1 dimer inhibitors from natural products. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |